GlobeNewswire 2021-11-08 atai Life Sciences to Host Conference Call and Webcast to Discuss Third Quarter 2021 Financial Resul...
Newsfile Corp 2021-11-06 DemeRx Inc. to Present at Wonderland Miami by Microdose
GlobeNewswire 2021-11-05 atai Life Sciences to Participate in Upcoming November Investor Conferences
GlobeNewswire 2021-11-01 atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort of Phase 2a Trial f...
GlobeNewswire 2021-10-20 2021 Psychedelic Investor Guide Released
GlobeNewswire 2021-10-19 atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness the Power of Innovative ...
GlobeNewswire 2021-10-11 atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for...
GlobeNewswire 2021-09-21 U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Announces Recent Investment in neurocare Grou...
GlobeNewswire 2021-09-21 DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder
GlobeNewswire 2021-09-15 atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto...
GlobeNewswire 2021-09-15 IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approv...
GlobeNewswire 2021-09-14 Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant dep...
GlobeNewswire 2021-09-09 atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in...
GlobeNewswire 2021-09-04 atai Life Sciences to Participate in Upcoming September Investor Conferences
GlobeNewswire 2021-08-16 atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update
GlobeNewswire 2021-08-12 atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Condition...
GlobeNewswire 2021-08-10 atai Life Sciences to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Resu...
GlobeNewswire 2021-08-07 atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference
GlobeNewswire 2021-08-04 IntelGenx Reports Second Quarter 2021 Financial Results
GlobeNewswire 2021-08-04 IntelGenx Strengthens Board with the Appointments of Dr. Srinivas G. Rao and Frank Stegert
GlobeNewswire 2021-07-28 atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the a...
GlobeNewswire 2021-07-08 atai Life Sciences to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
GlobeNewswire 2021-06-18 atai Life Sciences Announces Pricing of Upsized Initial Public Offering
GlobeNewswire 2021-06-11 atai Life Sciences Announces Launch of Initial Public Offering
GlobeNewswire 2021-05-14 IntelGenx Announces Initial Closing of atai Investment